Filters

IGSF8/CD316 Antibody

IGSF8/CD316 Antibody size: 0.1ml 263

Supplier BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price 263
Size 0.1ml
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long nameIGSF8/CD316 Primary Polyclonal Antibody
Also known asIGSF8/CD316 PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenIGSF8/CD316
SpecificityThis is a highly specific antibody against IGSF8/CD316
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
Immunogen range110-160/611
Subcellular locationExtracellular
SourceKLH conjugated synthetic peptide derived from mouse IGSF8
Gene ID number140559
Swiss ProtQ8R366
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen May also play a role on integrin-dependent morphology and motility functions, May be a negative regulator of cell motility: suppresses T-cell mobility coordinately with CD81, May participate in the regulation of neurite outgrowth and maintenance of the neural network in the adult brain, May regulate proliferation and differentiation of keratinocytes, associates with CD82 to suppress prostate cancer cell migration, regulates epidermoid cell reaggregation and motility on laminin-5 with CD9 and CD81 as key linkers, May play a key role in diverse functions ascribed to CD81 and CD9 such as oocytes fertilization or hepatitis C virus function
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names AA033172, AU041109, CD316, CD81 partner 3, ESTM34, EWI-2, Ewi2, Glu-Trp-Ile EWI motif-containing protein 2, IgSF8, Immunoglobulin superfamily member 8, KCT-4, Kct4, Keratinocyte-associated transmembrane protein 4, Prostaglandin regulatory-like protein, R75384, PGRL
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetIGSF8/CD316
Short nameIGSF8/CD316 Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative name member 8/CD316 (Antibody to), immunoglobulin superfamily
Alternative techniqueantibodies
Alternative to gene target IGSF8 and IDBG-103984 and ENSG00000162729 and 93185, IGSF8 and IDBG-630653 and ENSBTAG00000009982 and 519266, Igsf8 and IDBG-205334 and ENSMUSG00000038034 and 140559, Plasma membranes, member 8, protein binding, this GO :0005515 and protein binding and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0006928 and cellular component movement and biological process this GO :0007338 and single fertilization and biological process this GO :0007399 and nervous system development and biological process this GO :0007519 and skeletal muscle tissue development and biological process this GO :0008283 and cell proliferation and biological process this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0070062 and extracellular vesicular exosome and cellular component, this GO :0005515: protein binding, this GO :0005515: protein binding, immunoglobulin superfamily
Identity 17813
Gene IGSF8
Long gene name immunoglobulin superfamily member 8
Synonyms gene name immunoglobulin superfamily, member 8
Synonyms CD81P3 EWI2 PGRL CD316
Locus 1q23, 2
Discovery year 2002-01-08
GenBank acession AF407274
Entrez gene record 93185
Pubmed identfication 11504738 11673522
RefSeq identity NM_052868
Classification CD molecules V-set domain containing
Havana BLAST/BLAT OTTHUMG00000024075

Similar products

Subscribe to our Newsletter